Zynex Inc.  

(Public, OTCMKTS:ZYXI)   Watch this stock  
Find more results for OTC:ZYXI
0.000 (0.00%)
Jun 3 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.24 - 0.24
52 week 0.06 - 0.35
Open 0.24
Vol / Avg. 777.00/5,588.00
Mkt cap 7.44M
P/E     -
Div/yield     -
EPS -0.18
Shares 31.27M
Beta -9.53
Inst. own 0%
May 12, 2015
Q1 2015 Zynex Inc Earnings Call - Webcast
May 12, 2015
Q1 2015 Zynex Inc Earnings Release
Apr 2, 2015
Full Year 2014 Zynex Inc Earnings Call - Webcast
Apr 2, 2015
Full Year 2014 Zynex Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -28.40% -56.05%
Operating margin -24.25% -51.25%
EBITD margin - -65.05%
Return on average assets -53.60% -51.21%
Return on average equity - -336.81%
Employees 92 -
CDP Score - -


9990 Park Meadows Dr
LONE TREE, CO 80124-6739
United States - Map
+1-303-7034906 (Phone)
+1-800-4956695 (Fax)

Website links


Zynex, Inc. is the parent company of and conducts business within five subsidiaries: Zynex Medical, Inc. (ZMI), Zynex Neurodiagnostics, Inc. (ZND), Zynex Monitoring Solutions, Inc. (ZMS), Zynex Billing and Consulting, LLC (ZBC), a limited liability company and Zynex International (Zynex Europe ApS) (ZEU). The Company operates in three business segments: ZMI and ZBC, ZND and ZEU, and ZMS. ZMI designs, manufactures and markets United States Food and Drug Administration (FDA) cleared medical devices. ZBC provides outsourced billing services for private medical practices. ZND was formed to market electromyography (EMG), electroencephalography (EEG), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals and clinics across the world. ZEU was formed to progress Zynex’s international expansion. ZMS was formed to develop and market medical devices for non-invasive cardiac monitoring.

Officers and directors

Thomas Sandgaard Chairman of the Board, President, Chief Executive Officer
Age: 56
Brian Alleman Chief Financial Officer
Age: 58